Abstract
The CDX2 homeobox transcription factor plays key roles in intestinal development and homeostasis. CDX2 is downregulated during colorectal carcinogenesis, whereas overexpression of CDX2 results in growth inhibition and differentiation of colon carcinoma and intestinal cells. However, the means by which CDX2 functions remain poorly understood. p21/WAF1/CIP1 is one of the cyclin-dependent kinase inhibitors. In addition to its role in cell cycle control, p21 plays critical roles in differentiation and tumor suppression. The overlapping in both the expression and function of CDX2 and p21 in the small intestine and colon strongly suggests a link between these two genes. By means of luciferase reporter and electrophoretic mobility shift assays, we show here that CDX2 transactivated and physically interacted with the promoter of p21 in a p53-independent manner. Moreover, overexpression of CDX2 increased the mRNA expression of p21 in HT-29 colon carcinoma cells, as demonstrated by reverse transcription–polymerase chain reaction. These data suggest that p21 is a transcriptional target of CDX2. Our results may thus provide a new mechanism underlying the functions of CDX2.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Allan LA, Duhig T, Read M and Fried M . (2000). Mol. Cell. Biol., 20, 1291–1298.
Bai Y-Q, Akiyama Y, Nagasaki H, Yagi OK, Kikuchi Y, Saito N, Takeshita K, Iwai T and Yuasa Y . (2000). Mol. Carcinog., 28, 184–188.
Bai Y-Q, Yamamoto H, Akiyama Y, Tanaka H, Takizawa T, Koike M, Yagi OK, Saitoh K, Takeshita K, Iwai T and Yuasa Y . (2002). Cancer Lett., 176, 47–55.
Boudreau F, Rings EHHM, van Wering HM, Kim RK, Swain GP, Krasinski SD, Moffett J, Grand RJ, Suh ER and Traber PG . (2002). J. Biol. Chem., 277, 31909–31917.
Bromleigh VC and Freedman LP . (2000). Genes Dev., 14, 2581–2586.
Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T and Hannon GJ . (1995). Nature, 377, 552–557.
Bukholm IK and Nesland JM . (2000). Virchows Arch., 436, 224–228.
Chawengsaksophak K, James R, Hammond VE, Köntgen F and Beck F . (1997). Nature, 386, 84–87.
Dang DT, Mahatan CS, Dang LH, Agboola IA and Yang VW . (2001). Oncogene, 20, 4884–4890.
Di Cunto F, Topley G, Calautti E, Hsiao J, Ong L, Seth PK and Dotto GP . (1998). Science, 280, 1069–1072.
Dotto GP . (2000). Biochim. Biophys. Acta, 1471, M43–M56.
Ee HC, Erler T, Bhathal PS, Young GP and James R J . (1995). Am. J. Pathol., 147, 586–592.
El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B . (1993). Cell, 75, 817–825.
Freund JN, Domon-Dell C, Kedinger M and Duluc I . (1998). Biochem. Cell Biol., 76, 957–969.
Gartel AL, Goufman E, Najmabadi F and Tyner AL . (2000). Oncogene, 19, 5182–5188.
Gartel AL, Serfas MS, Gartel M, Goufman E, Wu GS, El-Deiry WS and Tyner AL . (1996). Exp. Cell Res., 227, 171–181.
Gartel AL and Tyner AL . (1999). Exp. Cell Res., 246, 280–289.
Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ . (1993). Cell, 75, 805–816.
Hinoi T, Lucas PC, Kuick R, Hanash S, Cho KR and Fearon ER . (2002). Gastroenterology, 123, 1565–1577.
Irwin M, Marin MC, Phillips AC, Seelan RS, Smith DI, Liu W, Flores ER, Tsai KY, Jacks T, Vousden KH and Kaelin Jr WG . (2000). Nature, 407, 645–648.
James R, Erler T and Kazenwadel J . (1994). J. Biol. Chem., 269, 15229–15237.
Koutsodontis G, Tentes I, Papakosta P, Moustakas A and Kardassis D . (2001). J. Biol. Chem., 276, 29116–29125.
Krasinski SD, van Wering HM, Tannemaat MR and Grand RJ . (2001). Am. J. Physiol. Gastrointest. Liver Physiol., 281, G69–G84.
Li R, Waga S, Hannon GJ, Beach D and Stillman B . (1994). Nature, 371, 534–537.
Lickert H, Domon C, Huls G, Wehrle C, Duluc I, Clevers H, Meyer BI, Freund JN and Kemler R . (2000). Development, 127, 3805–3813.
Lin J, Reichner C, Wu X and Levine AJ . (1996). Mol. Cell. Biol., 16, 1786–1793.
Lorentz O, Cadoret A, Duluc I, Capeau J, Gespach C, Cherqui G and Freund JN . (1999). Oncogene, 18, 87–92.
Lorentz O, Duluc I, Arcangelis AD, Simon-Assmann P, Kedinger M and Freund JN . (1997). J. Cell Biol., 139, 1553–1565.
Luo Y, Hurwitz J and Massague J . (1995). Nature, 375, 159–161.
Macdonald PM and Struhl G . (1986). Nature, 324, 537–545.
Mallo GV, Rechreche H, Frigerio J-M, Rocha D, Zweibaum A, Lacasa M, Jordan BR, Dusetti NJ, Dagorn J-C and Iovanna JL . (1997). Int. J. Cancer, 74, 35–44.
Mallo GV, Soubeyran P, Lissitzky JC, Andre F, Farnarier C, Marvaldi J, Dagorn J-C and Iovanna JL . (1998). J. Biol. Chem., 273, 14030–14036.
McGinnis W and Krumlauf R . (1992). Cell, 68, 283–302.
Moucadel V, Totaro MS, Dell CD, Soubeyran P, Dagorn JC, Freund JN and Iovanna JL . (2002). Biochem. Biophys. Res. Commun., 297, 607–615.
Mutoh H, Hakamata Y, Sato K, Eda A, Yanaka I, Honda S, Osawa H, Kaneko Y and Sugano K . (2002). Biochem. Biophys. Res. Commun., 294, 470–479.
Perlman H, Suzuki E, Simonson M, Smith RC and Walsh K . (1998). J. Biol. Chem., 273, 13713–13718.
Polyak K, Hamilton SR, Vogelstein B and Kinzler KW . (1996). Am. J. Pathol., 149, 381–387.
Silberg DG, Sullivan J, Kang E, Swain GP, Moffett J, Sund NJ, Sackett SD and Kaestner KH . (2002). Gastroenterology, 122, 689–696.
Silberg DG, Swain GP, Suh ER and Traber PG . (2000). Gastroenterology, 119, 961–971.
Smith RC, Branellec D, Gorski DH, Guo K, Perlman H, Dedieu JF, Pastore C, Mahfoudi A, Denèfle P, Isner JM and Walsh K . (1997). Genes Dev., 11, 1674–1689.
Soubeyran P, Andre F, Lissitzky JC, Mallo GV, Moucadel V, Roccabianca M, Rechreche H, Marvaldi J, Dikic I, Dagorn J-C and Iovanna JL . (1999). Gastroenterology, 117, 1326–1338.
Subramanian V, Meyer B and Evans GS . (1998). Differentiation, 64, 11–18.
Suh E, Chen L, Taylor J and Traber PG . (1994). Mol. Cell. Biol., 14, 7340–7351.
Suh E and Traber PG . (1996). Mol. Cell. Biol., 16, 619–625.
van Wering HM, Huibregtse IL, van der Zwan SM, de Bie MS, Dowling LN, Boudreau F, Rings EHHM, Grand RJ and Krasinski SD . (2002). J. Biol. Chem., 277, 27659–27667.
Waga S, Hannon GJ, Beach D and Stillman B . (1994). Nature, 369, 574–578.
Xiong Y, Hannon G, Zhang H, Casso D, Kobayashi R and Beach D . (1993). Nature, 366, 701–704.
Acknowledgements
We wish to thank Dr WG Kaelin Jr for providing the plasmid, and Drs H Yamamoto, Y Yanagisawa and Y Akiyama for valuable discussions. This study was supported in part by Grants-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Science, Sports and Culture of Japan.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bai, YQ., Miyake, S., Iwai, T. et al. CDX2, a homeobox transcription factor, upregulates transcription of the p21/WAF1/CIP1 gene. Oncogene 22, 7942–7949 (2003). https://doi.org/10.1038/sj.onc.1206634
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206634
Keywords
This article is cited by
-
Anticancer Activities of Biogenic Silver Nanoparticles Targeting Apoptosis and Inflammatory Pathways in Colon Cancer Cells
Journal of Cluster Science (2022)
-
How does intestinal-type intraductal papillary mucinous neoplasm emerge? CDX2 plays a critical role in the process of intestinal differentiation and progression
Virchows Archiv (2020)
-
Gastric- and intestinal-type IPMN: two of a kind?
Virchows Archiv (2020)
-
Ketogenesis contributes to intestinal cell differentiation
Cell Death & Differentiation (2017)
-
Motif co-regulation and co-operativity are common mechanisms in transcriptional, post-transcriptional and post-translational regulation
Cell Communication and Signaling (2015)